Your account is not claimed yet. You can sign up with ORCID to claim your account.

Bartlomiej Emil Krazinski (B E Krazinski, Bartłomiej E Kraziński, Bartlomiej E Krazinski)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 9

Top Venues

Biomolecules

Journal of personalized medicine

Nanomaterials (Basel, Switzerland)

BioMed research international

University of Warmia and Mazury in Olsztyn

Uniwersytet Warminsko-Mazurski (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Warmia and Mazury in Olsztyn Sep 1o 2017

Poland

Associate Professor :: School of Medicine, Department of Human Histology and Embryology

Education History

Uniwersytet Warminsko-Mazurski Oct 1o 2002 - Jun 24o 2007

Poland

PHD :: Faculty of Biology, Department of Animal Physiology

Publications

Jacek Kiezun, Marta Kieżun, Bartlomiej Emil Krazinski, Łukasz Paukszto, Anna Koprowicz-Wielguszewska, Zbigniew Kmieć, Janusz Godlewski
Galanin Receptors (GALR1, GALR2, and GALR3) Immunoexpression in Enteric Plexuses of Colorectal Cancer Patients: Correlation with the Clinico-Pathological Parameters. Biomolecules 12 (12) (2022)
Jacek Kiezun, Marta Kieżun, Bartlomiej Emil Krazinski, Łukasz Paukszto, Anna Koprowicz-Wielguszewska, Zbigniew Kmieć, Janusz Godlewski
Galanin Receptors (GALR1, GALR2, and GALR3) Immunoexpression in Enteric Plexuses of Colorectal Cancer Patients: Correlation with the Clinico-Pathological Parameters. Biomolecules 12 (12) (2022)
Jacek Kiezun, Marta Kieżun, Bartlomiej Emil Krazinski, Łukasz Paukszto, Anna Koprowicz-Wielguszewska, Zbigniew Kmieć, Janusz Godlewski
Galanin Receptors (GALR1, GALR2, and GALR3) Immunoexpression in Enteric Plexuses of Colorectal Cancer Patients: Correlation with the Clinico-Pathological Parameters. Biomolecules 12 (12) (2022)
Jacek Kiezun, Marta Kieżun, Bartlomiej Emil Krazinski, Łukasz Paukszto, Anna Koprowicz-Wielguszewska, Zbigniew Kmieć, Janusz Godlewski
Galanin Receptors (GALR1, GALR2, and GALR3) Immunoexpression in Enteric Plexuses of Colorectal Cancer Patients: Correlation with the Clinico-Pathological Parameters. Biomolecules 12 (12) (2022)
Jacek Kiezun, Marta Kieżun, Bartlomiej Emil Krazinski, Łukasz Paukszto, Anna Koprowicz-Wielguszewska, Zbigniew Kmieć, Janusz Godlewski
Galanin Receptors (GALR1, GALR2, and GALR3) Immunoexpression in Enteric Plexuses of Colorectal Cancer Patients: Correlation with the Clinico-Pathological Parameters. Biomolecules 12 (12) (2022)
Jacek Kiezun, Janusz Godlewski, Bartlomiej Emil Krazinski, Zygmunt Kozielec, Zbigniew Kmieć
Galanin Receptors (GalR1, GalR2, and GalR3) Expression in Colorectal Cancer Tissue and Correlations to the Overall Survival and Poor Prognosis of CRC Patients. International journal of molecular sciences 23 (7) (2022)
Adam Kern, Tomasz Stompór, Jolanta Kiewisz, Bartlomiej Emil Krazinski, Jacek Kiezun, Marta Kieżun, Jerzy Górny, Ewa Sienkiewicz, Leszek Gromadziński, Dariusz Onichimowski, Jacek Bil
The Impact of Sclerostin Levels on Long-Term Prognosis in Patients Undergoing Coronary Angiography: A Personalized Approach with 9-Year Follow-Up. Journal of personalized medicine 11 (3) (2021)
Katarzyna Ratajczak, Bartlomiej Emil Krazinski, Anna E Kowalczyk, Beata Dworakowska, Slawomir Jakiela, Magdalena Stobiecka
Optical Biosensing System for the Detection of Survivin mRNA in Colorectal Cancer Cells Using a Graphene Oxide Carrier-Bound Oligonucleotide Molecular Beacon. Nanomaterials (Basel, Switzerland) 8 (7) (2018)
Janusz Godlewski, J Kiezun, Bartlomiej Emil Krazinski, Z Kozielec, P M Wierzbicki, Z Kmiec
The Immunoexpression of YAP1 and LATS1 Proteins in Clear Cell Renal Cell Carcinoma: Impact on Patients' Survival. BioMed research international 2018 (2018)

Bartlomiej Emil Krazinski.css-eqlu8i{font-size:small;padding-left:4px;} (B E Krazinski, Bartłomiej E Kraziński, Bartlomiej E Krazinski)

Publication Activity (10 Years)

Top Topics

Top Venues

Bartlomiej Emil Krazinski (B E Krazinski, Bartłomiej E Kraziński, Bartlomiej E Krazinski)